Month: July 2019

MorphoSys’s Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilimab (MOR103/GSK3196165) in Rheumatoid Arthritis; MorphoSys Updates its Financial Guidance for 2019

Veradigm™ Partners with American College of Cardiology to develop next-generation research network: NCDR PINNACLE and Diabetes Collaborative Registries

Creates large scale, digitally enabled clinical quality improvement and research network in US CHICAGO--(BUSINESS WIRE)--#cardiology--Veradigm™, an Allscripts (NASDAQ: MDRX), business...

error: Content is protected !!